Literature DB >> 26169981

Maternal hypertension programs increased cerebral tissue damage following stroke in adult offspring.

Nicole M Ventura1, Albert Y Jin2,3, M Yat Tse4, Nichole T Peterson5, R David Andrew6,7, Jeffrey D Mewburn8, Stephen C Pang9.   

Abstract

The maternal system is challenged with many physiological changes throughout pregnancy to prepare the body to meet the metabolic needs of the fetus and for delivery. Many pregnancies, however, are faced with pathological stressors or complications that significantly impact maternal health. A shift in this paradigm is now beginning to investigate the implication of pregnancy complications on the fetus and their continued influence on offspring disease risk into adulthood. In this investigation, we sought to determine whether maternal hypertension during pregnancy alters the cerebral response of adult offspring to acute ischemic stroke. Atrial natriuretic peptide gene-disrupted (ANP(-/-)) mothers exhibit chronic hypertension that escalates during pregnancy. Through comparison of heterozygote offspring born from either normotensive (ANP(+/-WT)) or hypertensive (ANP(+/-KO)) mothers, we have demonstrated that offspring exposed to maternal hypertension exhibit larger cerebral infarct volumes following middle cerebral artery occlusion. Observation of equal baseline cardiovascular measures, cerebrovascular structure, and cerebral blood volumes between heterozygote offspring suggests no added influences on offspring that would contribute to adverse cerebral response post-stroke. Cerebral mRNA expression of endothelin and nitric oxide synthase vasoactive systems demonstrated up-regulation of Et-1 and Nos3 in ANP(+/-KO) mice and thus an enhanced acute vascular response compared to ANP(+/-WT) counterparts. Gene expression of Na(+)/K(+) ATPase channel isoforms, Atp1a1, Atp1a3, and Atp1b1, displayed no significant differences. These investigations are the first to demonstrate a fetal programming effect between maternal hypertension and adult offspring stroke outcome. Further mechanistic studies are required to complement epidemiological evidence of this phenomenon in the literature.

Entities:  

Keywords:  Endothelin; Fetal programming; Hypertension; Na+/K+-ATPase; Natriuretic peptide; Nitric oxide synthase; Pregnancy; Stroke

Mesh:

Substances:

Year:  2015        PMID: 26169981     DOI: 10.1007/s11010-015-2498-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  52 in total

1.  Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.

Authors:  D J Barker; C Osmond; J Golding; D Kuh; M E Wadsworth
Journal:  BMJ       Date:  1989-03-04

2.  Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine.

Authors:  Z Huang; P L Huang; J Ma; W Meng; C Ayata; M C Fishman; M A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

3.  Gestational hypertension and the developmental origins of cardiac hypertrophy and diastolic dysfunction.

Authors:  David W J Armstrong; M Yat Tse; Philip G Wong; Nicole M Ventura; Jalna A Meens; Amer M Johri; Murray F Matangi; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2014-04-10       Impact factor: 3.396

4.  Evaluation of plasma endothelin-1 levels in patients with cerebral infarction.

Authors:  Zekeriya Alioğlu; Asim Orem; Ismail Bülbül; Cavit Boz; Mehmet Ozmenoğlu; Birgül Vanizor
Journal:  Angiology       Date:  2002 Jan-Feb       Impact factor: 3.619

Review 5.  Targeting eNOS for stroke protection.

Authors:  Matthias Endres; Ulrich Laufs; James K Liao; Michael A Moskowitz
Journal:  Trends Neurosci       Date:  2004-05       Impact factor: 13.837

6.  Effect of native and synthetic atrial natriuretic factor on cyclic GMP.

Authors:  P Hamet; J Tremblay; S C Pang; R Garcia; G Thibault; J Gutkowska; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

7.  Cytochemical detection of superoxide in cerebral inflammation and ischemia in vivo.

Authors:  C D Kontos; E P Wei; J I Williams; H A Kontos; J T Povlishock
Journal:  Am J Physiol       Date:  1992-10

8.  Atrial natriuretic factor: a hormone produced by the heart.

Authors:  A J de Bold
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

9.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

10.  The gene encoding atrial natriuretic peptide and the risk of human stroke.

Authors:  S Rubattu; P Ridker; M J Stampfer; M Volpe; C H Hennekens; K Lindpaintner
Journal:  Circulation       Date:  1999-10-19       Impact factor: 29.690

View more
  2 in total

1.  Developmental origins of pregnancy-induced cardiac changes: establishment of a novel model using the atrial natriuretic peptide gene-disrupted mice.

Authors:  Nicole M Ventura; Terry Y Li; M Yat Tse; Logan Richard; Chandrakant Tayade; Albert Y Jin; R David Andrew; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2018-05-25       Impact factor: 3.396

2.  Application of Optical Coherence Tomography and Contrast Sensitivity Test for Observing Fundus Changes of Patients With Pregnancy-Induced Hypertension Syndrome.

Authors:  Zhixue Wang; Yuanyuan Zou; Wenying Li; Xueyan Wang; Min Zhang; Wenying Wang
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.